☆ 4.7 Letter

Bone marrow stromal cell-mediated degradation of CD20 leads to primary rituximab resistance in mantle cell lymphoma

LEUKEMIA (2021)

Get Full Text
Add to Collection

Journal

LEUKEMIA
Volume 35, Issue 5, Pages 1506-1510

Publisher

SPRINGERNATURE
DOI: 10.1038/s41375-020-01035-x

Keywords

-

Categories

Oncology Hematology

Funding

  1. Japan Society for the Promotion of Science
  2. Janssen Pharmaceutical K.K.
  3. Bristol-Myers Squibb Foundation
  4. Celgene K.K.

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.